deferoxamine has been researched along with Injuries, Spinal in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobsen, EJ | 1 |
McCall, JM | 1 |
Ayer, DE | 1 |
Van Doornik, FJ | 1 |
Palmer, JR | 1 |
Belonga, KL | 1 |
Braughler, JM | 1 |
Hall, ED | 1 |
Houser, DJ | 1 |
Krook, MA | 1 |
1 other study available for deferoxamine and Injuries, Spinal
Article | Year |
---|---|
Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma.
Topics: Amines; Animals; Antioxidants; Craniocerebral Trauma; Drug Evaluation, Preclinical; Lipid Peroxidati | 1990 |